You are here

Genentech

Genentech lays off 143 workers at South San Francisco campus

Fierce Biotech

Wed, 06/11/25 - 10:24 pm

Mapping out opportunities to reduce emissions in clinical trials

Clinical Trials Arena

Wed, 05/28/25 - 10:55 am

clinical trials

Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B

Fierce Biotech

Wed, 05/21/25 - 11:17 am

Orionis Biosciences

Roche looks to a Flagship startup in search of new immune drugs

BioPharma Dive

Wed, 04/23/25 - 09:50 am

Repertoire Immune Medicines

autoimmune disease

Tenecteplase compares favorably to alteplase in new comparison of FDA-approved stroke drugs

Cardiovascular Business

Thu, 03/13/25 - 11:18 pm

Roche to house its CVRM research work at Harvard's new research campus

Fierce Biotech

Fri, 03/7/25 - 11:21 am

cardiovascular disease

Roche continues regulatory run with acute stroke expansion for heart attack drug

BioSpace

Tue, 03/4/25 - 11:03 am

ischemic stroke

Genentech archives diversity reports amid site update, examines ‘potential implications of executive orders’

Fierce Biotech

Thu, 02/13/25 - 10:08 pm

Kineta sells Genentech and Merck deals to investor ahead of TuHURA merger

Fierce Biotech

Mon, 02/10/25 - 10:19 am

TuHURA Biosciences

Pacira Pharmaceuticals

Genentech eyes lupus market for Gazyva with positive Phase III data readout

Clinical Trials Arena

Fri, 02/7/25 - 11:10 am

clinical trials

FDA Approves Susvimo for Diabetic Macular Edema

Managed Healthcare Executive

Tue, 02/4/25 - 06:14 pm

diabetic macular edema

Roche Partners With COUR in Autoimmune Deal Potentially Worth More Than $900M

BioSpace

Tue, 12/3/24 - 11:23 am

Cour Pharmaceuticals

autoimmune disease

immune tolerance platform

Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals

Pharma Voice

Thu, 11/21/24 - 11:12 am

Roche culls cough candidate, pivots KRAS program after revaluing entire pipeline

Fierce Biotech

Wed, 10/23/24 - 11:29 am

Another Roche MAGE-A4 trial disappears, withdrawn without enrolling after strategic review

Fierce Biotech

Fri, 10/18/24 - 11:34 am

clinical trials

bispecific antibodies

Genentech buys Regor's next-gen CDK inhibitors for $850M

Pharmaphorum

Tue, 10/1/24 - 09:46 am

Regor Therapeutics

Roche doubles down with another subcutaneous FDA nod, this one for MS star Ocrevus

Fierce Pharma

Sun, 09/15/24 - 06:17 pm

Genentech's cancer restructure was made 'for scientific reasons': exec

Fierce Biotech

Tue, 09/10/24 - 08:44 am

Novartis and Genentech’s Xolair is rising rapidly on TV

Medical Marketing and Media

Thu, 08/29/24 - 06:11 pm

Genentech telegraphs 93 layoffs in California after sharing plans to shutter cancer immunology research unit

Fierce Biotech

Wed, 08/28/24 - 11:36 am

Pages